Literature DB >> 17404822

Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.

Rubén Francés1, José M González-Navajas, Pedro Zapater, Carlos Muñoz, Rocío Caño, Sonia Pascual, Dorkas Márquez, Francia Santana, Miguel Pérez-Mateo, José Such.   

Abstract

Translocation of intestinal bacteria to ascitic fluid is, probably, the first step in the development of spontaneous bacterial peritonitis in patients with cirrhosis. Proteins of the complement system are soluble mediators implicated in the host immune response to bacterial infections and its activation has been traditionally considered to be an endotoxin-induced phenomenon. The aim of this study was to compare the modulation of these proteins in response to the presence of bacterial DNA and/or endotoxin in patients with advanced cirrhosis and ascites in different clinical conditions. Groups I and II consisted of patients without/with bacterial DNA. Group III included patients with spontaneous bacterial peritonitis and Group IV with patients receiving norfloxacin as secondary long-term prophylaxis of spontaneous bacterial peritonitis. Serum and ascitic fluid levels of endotoxin and truncated residues of the complement system were measured by ELISA. The complement system is triggered in response to bacterial DNA, as evidenced by significantly increased levels of C3b, membrane attack complex, and C5a in patients from Groups II and III compared with patients without bacterial DNA (Group I) and those receiving norfloxacin (Group IV). Gram classification did not further differentiate the immune response between patients within groups II and III, even though endotoxin levels were, as expected, significantly higher in patients with bacterial DNA from gram-negative microorganisms. The complement protein activation observed in patients with bacterial DNA in blood and ascitic fluid is indistinguishable from that observed in patients with spontaneous bacterial peritonitis and may occur in an endotoxin-independent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404822     DOI: 10.1007/s10875-007-9090-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  29 in total

1.  Bacterial translocation: cause or consequence of decompensation in cirrhosis?

Authors:  G García-Tsao
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

Review 2.  Spontaneous bacterial peritonitis.

Authors:  C Guarner; G Soriano
Journal:  Semin Liver Dis       Date:  1997       Impact factor: 6.115

3.  Bacterial translocation from the intestines.

Authors:  R D Berg
Journal:  Jikken Dobutsu       Date:  1985-01

4.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

5.  Bacterial translocation of enteric organisms in patients with cirrhosis.

Authors:  I Cirera; T M Bauer; M Navasa; J Vila; L Grande; P Taurá; J Fuster; J C García-Valdecasas; A Lacy; M J Suárez; A Rimola; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

6.  Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12.

Authors:  J H Chace; N A Hooker; K L Mildenstein; A M Krieg; J S Cowdery
Journal:  Clin Immunol Immunopathol       Date:  1997-08

7.  Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites.

Authors:  R Francés; C Muñoz; P Zapater; F Uceda; I Gascón; S Pascual; M Pérez-Mateo; J Such
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

9.  Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.

Authors:  José Such; Rubén Francés; Carlos Muñoz; Pedro Zapater; Juan A Casellas; Ana Cifuentes; Francisco Rodríguez-Valera; Sonia Pascual; Javier Sola-Vera; Fernando Carnicer; Francisco Uceda; José M Palazón; Miguel Pérez-Mateo
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  Paracentesis of ascitic fluid. A safe procedure.

Authors:  B A Runyon
Journal:  Arch Intern Med       Date:  1986-11
View more
  13 in total

1.  Immunology and the evaluation of risk factors for development of spontaneous bacterial peritonitis.

Authors:  Charles J Diskin
Journal:  Dig Dis Sci       Date:  2007-10-17       Impact factor: 3.199

2.  Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites.

Authors:  Bashar M Attar; Christopher M Moore; Magdalena George; Nicolae Ion-Nedelcu; Rafael Turbay; Annamma Zachariah; Guiliano Ramadori; Jawed Fareed; David H Van Thiel
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.

Authors:  Paula Piñero; Oriol Juanola; Ana Gutiérrez; Pedro Zapater; Paula Giménez; Anna Steinert; Laura Sempere; José M González-Navajas; Jan H Niess; Rubén Francés
Journal:  J Mol Med (Berl)       Date:  2017-09-06       Impact factor: 4.599

Review 4.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

5.  Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections.

Authors:  Mette Bjerre; Peter Holland-Fischer; Henning Grønbæk; Jan Frystyk; Troels K Hansen; Hendrik Vilstrup; Allan Flyvbjerg
Journal:  World J Hepatol       Date:  2010-06-27

6.  Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis.

Authors:  R Francés; J M González-Navajas; P Zapater; C Muñoz; R Caño; S Pascual; F Santana; D Márquez; M Pérez-Mateo; J Such
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

7.  Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhotics.

Authors:  Bashar M Attar; Magdalena George; Nicolae Ion-Nedelcu; Guilliano Ramadori; David H Van Thiel
Journal:  World J Hepatol       Date:  2014-02-27

Review 8.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 9.  Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis.

Authors:  Pedro Zapater; José Manuel González-Navajas; José Such; Rubén Francés
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.

Authors:  Paula Gimenez; Irma Garcia-Martinez; Rubén Francés; Jose M Gonzalez-Navajas; Montserrat Mauri; Rocío Alfayate; Susana Almenara; Cayetano Miralles; Jose M Palazon; Fernando Carnicer; Sonia Pascual; José Such; José F Horga; Pedro Zapater
Journal:  Liver Int       Date:  2018-06-19       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.